Ritonavir
Specifications
155213-67-5CAS Number
605-001-5EC Number
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamateIUPAC Name
C37H48N6O5S2Chemical Formula
720.9 g/molMolecular Weight
ritonavir; 155213-67-5; Norvir; ABT-538; A-84538; Abbott 84538; ABBOTT-84538; Empetus; Ritomune; Ritovir; Viekirax; Viriton; Ritonavirum; ABT538; DTXSID1048627; CHEBI:45409; NSC-693184; O3J8G9O825; NSC693184; DTXCID8028553; PAXLOVID COMPONENT RITONAVIR; VIEKIRAX COMPONENT RITONAVIR; XIANNUOXIN COMPONENT RITONAVIR; 2,4,7,12-Tetraazatridecan-13-oic acid, 10-hydroxy-2-methyl-5-(1-methylethyl)-1-(2-(1-methylethyl)-4-thiazolyl)-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (5S-(5R*,8R*,10R*,11R*))-; 1,3-thiazol-5-ylmethyl N-((2S,3S,5S)-3-hydroxy-5-(((2S)-3-methyl-2-((methyl-((2-propan-2-yl-1,3-thiazol-4-yl)methyl)carbamoyl)amino)butanoyl)amino)-1,6-di(phenyl)hexan-2-yl)carbamate; 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-di(phenyl)hexan-2-yl]carbamate; 2,4,7,12-Tetraazatridecan-13-oic acid, 10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, [5S-(5R*,8R*,10R*,11R*)]-; ritonavir 100 mg; Ritonavir film coated; RefChem:6492; J05AE03; MFCD00927142; RTV; ABT 538; 2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)-; CHEMBL163; C37H48N6O5S2; 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate; thiazol-5-ylmethyl ((2S,3S,5S)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl)carbamate; thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate; Ritonavir [USAN]; NCGC00159462-02; NCGC00183130-01; Norvir Softgel; 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide; RIT; DRG-0244; SMR000466395; Norvir (TM); Norvir (TN); CAS-155213-67-5; HSDB 7160; TMC 114r; UNII-O3J8G9O825; s1185; Ritonavir RS; Ritonavir CRS; 1hxw; 3prs; 3tne; 4eyr; Ritonavir [USAN:USP:INN:BAN]; 2,7,10,12-TETRAAZATRIDECANOIC ACID, 4-HYDROXY-12-METHYL-9-(1-METHYLETHYL)-13-(2-(1-METHYLETHYL)-4-THIAZOLYL)-8,11-DIOXO-3,6-BIS(PHENYLMETHYL)-, 5-THIAZOLYLMETHYL ESTER, (3S,4S,6S,9S)-; 5-Thiazolylmethyl [(alphaS)-alpha-[(1S,3S)-1-hydroxy-3-[(2S)-2-[3-[(2-isopropyl-4-thiazolyl)methyl]-3-methylureido]-3-methylbutyramido]-4-phenylbutyl]phenethyl]carbamate; Ritonavir & PLGA; Ritonavir (Standard); 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 1sh9; RITONAVIR [INN]; RITONAVIR [JAN]; RITONAVIR [MI]; RTV, r; RITONAVIR [HSDB]; Ritonavir [ep monograph]; RITONAVIR [VANDF]; Epitope ID:231716; RITONAVIR [MART.]; RITONAVIR [USP-RS]; RITONAVIR [WHO-DD]; RITONAVIR [WHO-IP]; SCHEMBL6679; Ritonavir (JAN/USP/INN); BIDD:PXR0023; BDBM520; RITONAVIR [EMA EPAR]; MLS000759541; MLS001424063; MLS006011764; BIDD:GT0387; Ritonavir - Bio-X trade mark; GTPL8804; orb1308324; orb3141290; RITONAVIR [ORANGE BOOK]; RITONAVIR [USP IMPURITY]; Ritonavir, >=98% (HPLC); RITONAVIR [USP MONOGRAPH]; KALETRA COMPONENT RITONAVIR; NCDNCNXCDXHOMX-XGKFQTDJSA-N; GLXC-02733; HMS2051B08; HMS2235O10; HMS3715L22; Pharmakon1600-01502391; RITONAVIRUM [WHO-IP LATIN]; MSK11461; Tox21_112969; Tox21_113431; AC-733; BDBM50088504; EBC-06098; EX-A15181; HB6070; HY-90001R; NSC760369; STK634209; Ritonavir for peak identification CRS; AKOS000280930; Tox21_112969_1; CCG-101007; CS-0432; DB00503; FR16561; KS-5017; NC00257; NSC 693184; NSC 760369; NSC-760369; MRF-0000287; NCGC00159462-03; NCGC00159462-04; NCGC00159462-07; NCGC00159462-20; Ritonavir 100 microg/mL in Acetonitrile; (1,3-thiazol-5-yl)methyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate; BR164353; HY-90001; SY073242; MLS000759541-02; R0116; R3577; SW197637-2; C07240; D00427; EN300-119505; AB00639991-06; AB00639991-08; AB00639991_09; AB00639991_10; A 84538; F358080; Q422618; BRD-K51485625-001-07-6; BRD-K51485625-001-08-4; Z1521553599; (2S, 3S, 5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinvl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane; (2S,3S,5S )-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl) methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl) methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane; (2S,3S,5S)-5-(N-(N((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane; (2S,3S,5S)-5-(N-(N-((N-MethyI-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1.6-diphenyl-3-hydroxyhexane; (2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl) methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane; (2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino )-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane; (2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1 .6-diphenyl-3-hydroxyhexane; (2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane; (2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3hydroxyhexane; (2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1.6-diphenyl-3-hydroxyhexane; (3S,4S,6S,9S)-4-Hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-te traazatridecanoic acid 5-thiazolylmethyl ester; 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamateEE; 2,4,7,12-TETRAAZATRIDECAN-13-OIC ACID, 10-HYDROXY-2-METHYL-5-(1-METHYLETHYL)-1-(2-(1-METHYLETHYL)-4-THIAZOLYL)-3,6-DIOXO-8,11-BIS(PHENYLMETHYL)-5-THIAZOLYLMETHYL ESTER (5S-(5R*,8R*,10R*,11R*))-; 5-Thiazolylmethyl (3S,4S,6S,9S)-4-hydroxy-12-methyl-9- (1-methylethyl)-13-[2- (1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis (phenylmethyl)-2,7,10,12-tetraazatridecanoate; 5-Thiazolylmethyl [(2S,3S,5S)-3-Hydroxy-5-[(S)-2-[3-[(2-isopropyl-4-thiazolyl)methyl]-3-methylureido]-3-methylbutanamido]-1,6-diphenyl-2-hexyl]carbamate; N-[(2S,4S,5S)-4-Hydroxy-1,6-diphenyl-5-({[(1,3-thiazol-5-yl)methoxy]carbonyl}amino)hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide; N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N(2)-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide; N1-((1S,3S,4S)-1-benzyl-3-hydroxy-5-phenyl-4-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}pentyl)-N2-{[[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)amino]carbonyl}-L-valinamide; thiazol-5-ylmethyl (2S,3S,5S)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-ylcarbamate; thiazol-5-ylmethyl((2S,3S,5S)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl)carbamate; RinotavirSynonyms
Products Containing Ritonavir
팍스로비드정(니르마트렐비르, 리토나비르)노비르정(리토나비르)カレトラ配合内用液カレトラ配合錠PAXLOVID 150 MG + 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULALOPINAVIR/RITONAVIR VIATRIS 200 MG/50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLOPINAVIR/RITONAVIR VIATRIS 100 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLOPINAVIR/RITONAVIR ACCORD 200 MG/ 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGKALETRA 200 mg/50 mg COMPRIMIDOS RECUBIERTOS CON PELICULARITONAVIR ACCORD 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGNORVIR 100MG POLVO PARA SUSPENSION ORALNORVIR 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Page 1 of 7
Companies Selling Ritonavir
CT
Công ty TNHH BRV HealthcareViet NamAP
Aurobindo Pharma LimitedIndiaMP
Macleods Pharmaceuticals LimitedIndiaAD
Abbvie Deutschland GmbH & Co. KGGermanyPage 1 of 4